SyrSpend®

Fagron's range of oral suspending vehicles, SyrSpend® SF, offers a solution for different patient groups by providing pharmaceutical stability, dosage consistency, and patient comfort with each preparation.

The importance of compounding vehicles 

There are many ways to administer medicine, and oral administration is the most common route due to its many benefits. It is non-invasive, cost-effective, more comfortable than other routes, and the patient can administer the medicine themselves. However, it also comes with challenges like the need for dosing adjustment, allergies and intolerances, and patients with (severe) dysphagia, or patients on an enteral feeding tube. In those cases, the compounding pharmacist will prepare the medication with an oral suspending vehicle. Oral vehicles are types of liquid solutions for administration of medication. Fagron’s range of oral suspending vehicles, SyrSpend® SF, offers a solution for different patient groups by providing pharmaceutical stability, dosage consistency, and patient comfort with each preparation. 

Concept brochures

SyrSpend® SF vehicles

Product brochure

Open pdf

The uniqueness of SyrSpend® SF

Fagron’s SyrSpend® SF solutions are suitable for even the most vulnerable patient groups. All vehicles in the SyrSpend® SF range offer superior suspending properties and have proven compatibility and more stability studies than any other vehicle. The use of starch means that SyrSpend® SF is virtually chemically inert and therefore compatible with a broad range of APIs. In addition, SyrSpend® SF PH4 Neo is especially suitable for neonates, as it does not contain sugar, sorbitol, colorants, parabens, or any other harmful or controversial ingredients. To see all API combinations that have been scientifically studied for chemical, physical, and microbiological stability, see the compatibility table in Compounding Matters formulations database.

Product brochures

SyrSpend® SF dosing accuracy

Studies have shown that when over 5000 samples in SyrSpend® SF are analyzed of 74 different types of medication, all deliver exactly the right dose, making dosing with SyrSpend® SF a safe option for oral liquid medication.

Key facts and figures

compatibility studies
140+
concept products
5
APIs in compatibility table
130+

SyrSpend® SF PH4 Neo

One of the most important precepts of pediatric and neonatal care is that children cannot be considered small adults. Infancy and childhood mark a period of rapid growth and development. Excipients that need to be avoided in neonates and infants include ethanol, propylene glycol, polyethylene glycol, benzyl alcohol, parabens, benzoic acid, benzoic acid and its derivatives, sucrose, fructose, mannitol, sorbitol, xylitol, aspartame, and colorings. In addition, SyrSpend® SF PH4 NEO is free of sugar, sorbitol, colorants, parabens or any other harmful or controversial ingredients. SyrSpend® SF PH4 NEO is preserved with 0.2% Sorbic acid, which makes it suitable for all patient groups.

  • Free of controversial ingredients
  • Quick and easy preparation
  • Suitable for all patient groups
See SyrSpend® SF PH4 Neo formulations